Cell Source Inc (CLCS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cell Source Inc (CLCS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9436
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cell Source Inc (Cell Source), formerly Ticket to See Inc, is a biotechnology company that offers development of cell therapy treatments based on the management of immune tolerance. The company’s Veto Cells are white blood cells taken from either the patient or a healthy third-party donor and used to prevent post-transplant infections resulting from common viruses that cause post-transplant complications and mortality. It also provides anti-rejection Veto Cell, Veto Cell genetically modified cells for allogeneic treatment and Veto Cell for non-malignant disease. Cell Source’ patented Veto-Cell technology represents a breakthrough in immune system management safe and selective tolerizing of immune response, Anti-rejection Veto Cells enable the selective attenuation of immune system response and others. The company provides revolutionizing transplantation and cancer treatment utilizing immune tolerance technology. Cell Source is headquartered in New York, the US.

Cell Source Inc (CLCS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Source Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Source Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cell Source Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cell Source Plans to Form Joint Venture 10
Licensing Agreements 11
CellSource Enters into Licensing Agreement with American CryoStem 11
Equity Offering 12
Cell Source Raises USD5 Million in Private Placement of Units 12
Cell Source Inc – Key Competitors 13
Cell Source Inc – Key Employees 14
Cell Source Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Cell Source Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Source Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Source Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Source Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cell Source Plans to Form Joint Venture 10
CellSource Enters into Licensing Agreement with American CryoStem 11
Cell Source Raises USD5 Million in Private Placement of Units 12
Cell Source Inc, Key Competitors 13
Cell Source Inc, Key Employees 14
Cell Source Inc, Subsidiaries 15

List of Figures
Cell Source Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Source Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cell Source Inc (CLCS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析
    Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Datatec Ltd (DTC):企業の財務・戦略的SWOT分析
    Datatec Ltd (DTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kronos Incorporated:企業の戦略・SWOT・財務分析
    Kronos Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kronos Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Celulosa Arauco y Constitucion SA:企業の戦略的SWOT分析
    Celulosa Arauco y Constitucion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Selvita SA (SLV):企業の財務・戦略的SWOT分析
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • Taiyo Nippon Sanso Corp (4091):企業の財務・戦略的SWOT分析
    Taiyo Nippon Sanso Corp (4091) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ViewRay Inc (VRAY):医療機器:M&Aディール及び事業提携情報
    Summary ViewRay Inc (ViewRay) is a medical device company that develops radiation therapy technology for the treatment of cancer. The company provides MRIdian, a radiation therapy solution that enables treatment and real-time imaging of a patient’s anatomy simultaneously. It offers MRIdian integrate …
  • ACWA Power International:企業の戦略的SWOT分析
    ACWA Power International - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Madhya Pradesh Power Generating Company Ltd:企業の発電所・SWOT分析2018
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • The Scotts Miracle-Gro Company:企業の戦略・SWOT・財務分析
    The Scotts Miracle-Gro Company - Strategy, SWOT and Corporate Finance Report Summary The Scotts Miracle-Gro Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Forge Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Forge Energy LLC (Forge Energy) is an independent oil and gas exploration and production company that acquires, explores, operates, manages, produces and develops natural oil and gas properties. The company offers services such as consolidation, acquisition, leasing, and exploitation of matu …
  • Rentokil Initial plc (RTO):企業の財務・戦略的SWOT分析
    Rentokil Initial plc (RTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cardiff University-製薬・医療分野:企業M&A・提携分析
    Summary Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of enginee …
  • IMPAC Mortgage Holdings Inc (IMH):企業の財務・戦略的SWOT分析
    IMPAC Mortgage Holdings Inc (IMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Impresa Pizzarotti & C. S.p.A.:企業の戦略・SWOT・財務情報
    Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Globeimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Martin Midstream Partners LP (MMLP):企業の財務・戦略的SWOT分析
    Martin Midstream Partners LP (MMLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • China Resources Pharmaceutical Group Ltd (3320):製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆